AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimirun M 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Avonic Life Sciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimirun M 1mg/500mg Tablet ER

Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Diabex Duo should be taken with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication forms part of a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms—sweating, dizziness, headache, trembling—and how to treat them promptly. Maintaining consistent meals and carrying a fast-acting glucose source (e.g., sugary snacks, juice) is vital. Alcohol consumption increases hypoglycemia risk and should be limited. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart conditions should consult their physician prior to use. Pregnant or lactating women must also seek medical advice before commencing treatment. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to monitor blood cell counts and liver function.

Primary Ingredients of Glimirun M 1mg/500mg Tablet ER

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Glimirun M 1mg/500mg Tablet ER

Managing Type 2 diabetes

Major Benefits of Glimirun M 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimirun M 1mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimirun M 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimirun M 1mg/500mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not crush, chew, or fracture it. Consume Glimirun M 1mg/500mg Extended-Release tablets with food.

How Glimirun M 1mg/500mg Tablet ER works:

Glimirun M 1mg/500mg Extended-Release tablets unite glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimirun M 1mg/500mg Tablet ER with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimirun M 1mg/500mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glimirun M 1mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimirun M 1mg/500mg Extended-Release tablets to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised. Avoid Glimirun M 1mg/500mg Extended-Release tablets in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimirun M 1mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate hepatic dysfunction may begin on a reduced dose; however, its use is contraindicated in those with severe liver disease. Physician consultation is advised.

What if you forget to take Glimirun M 1mg/500mg Tablet ER :

Should you forget a Glimirun M 1mg/500mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimirun M 1mg/500mg Tablet ER

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Glimirun M 1mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimirun M 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and a slow heart rate. If you experience these, discontinue Glimirun M 1mg/500mg Tablet ER and seek immediate medical attention.
Glimirun M 1mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimirun M 1mg/500mg Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimirun M 1mg/500mg Tablet ER can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological symptoms such as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimirun M 1mg/500mg ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimirun M 1mg/500mg ER tablets with alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimirun M 1mg/500mg Tabl...
43
MRP 50
14% off